G861-0155 Screening compound: 2-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]-6-[2-(4-fluorophenyl)-2-oxoethyl]-8,9-dimethoxy-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-5-one

G861-0155 Screening compound: 2-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]-6-[2-(4-fluorophenyl)-2-oxoethyl]-8,9-dimethoxy-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-5-one
G861-0155 Screening compound: 2-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]-6-[2-(4-fluorophenyl)-2-oxoethyl]-8,9-dimethoxy-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-5-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G861-0155
2-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]-6-[2-(4-fluorophenyl)-2-oxoethyl]-8,9-dimethoxy-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-5-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G861-0155

Molecular Formula

C26H25FN6O4 (C26 H25 FN6 O4)

Compound Name

2-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]-6-[2-(4-fluorophenyl)-2-oxoethyl]-8,9-dimethoxy-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-5-one

IUPAC name

2-[2-(35-dimethyl-1H-pyrazol-1-yl)ethyl]-6-[2-(4-fluorophenyl)-2-oxoethyl]-89-dimethoxy-5H6H-[124]triazolo[15-c]quinazolin-5-one

SMILES

Cc1cc(C)nn1CCc(nc1-c(cc(c(OC)c2)OC)c2N2CC(c(cc3)ccc3F)=O)nn1C2=O

InChI

InChI=1S/C26H25FN6O4/c1-15-11-16(2)32(29-15)10-9-24-28-25-19-12-22(36-3)23(37-4)13-20(19)31(26(35)33(25)30-24)14-21(34)17-5-7-18(27)8-6-17/h5-8,11-13H,9-10,14H2,1-4H3

InChI Key

YEVJCUBMETVFGH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27164976

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

504.52

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.660

Distribution Coefficient, logD

2.659

Water Solubility, LogSw

-3.02

Polar Surface Area

82.579

Acid Dissociation Constant (pKa)

17.29

Base Dissociation Constant (pKb)

4.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

G861-0155 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

Human Kinases Annotated Library (2415 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G861-0155 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G861-0155?
Check Price and Availability of G861-0155, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G861-0155 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G861-0155
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G861-0155
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G861-0155 available by request